GSK Reports Positive Phase III Results for Low-Car...
Category : Clinical Trial Update 24 October 2025GSK plc has announced positive phase III results from its clinical programme evaluating a next-gener...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
GSK plc has announced positive phase III results from its clinical programme evaluating a next-gener...
Novartis announced that its biologic therapy Cosentyx (secukinumab) achieved the primary endpoint an...
AnnJi Pharmaceutical Co., Ltd. (TWSE: 7754) announced that the U.S. Food and Drug Administration (FD...
CAGE Bio Inc., a clinical-stage biotechnology company focused on immunomodulatory therapies for derm...
Merck (known as MSD outside the U.S. and Canada) presented additional results from two Phase 3 clini...